Evidence map›Paper›PMID 32335305›Full record

Observational studyJournal of vascular surgery2021

Meaningful change in 6-minute walk in people with peripheral artery disease.

Mary M McDermott, Lu Tian, Michael H Criqui, Luigi Ferrucci, Michael S Conte, Lihui Zhao, Lingyu Li, Robert Sufit, Tamar S Polonsky, Melina R Kibbe and 3 more

Abstract readObservational Study
In one paragraph

Observational study in Journal of vascular surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Article
  17. Minimal clinically important difference of the 6-Minute walk test and daily step count at 3 months following surgery for lumbar spinal stenosis.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Mary M McDermottDepartment of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Ill; Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Ill. Electronic address: mdm608@northwestern.edu.
Lu TianDepartment of Biomedical Science Data, Stanford Medicine, Stanford University, Stanford, Calif.
Michael H CriquiDepartment of Family Medicine and Public Health, University of California at San Diego, La Jolla, Calif.
Luigi FerrucciDivision of Intramural Research, National Institute on Aging, National Institutes of Health, Bethesda, Md.
Michael S ConteDivision of Vascular and Endovascular Surgery, University of California, San Francisco, San Francisco, Calif.
Lihui ZhaoDepartment of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Ill.
Lingyu LiDepartment of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Ill.
Robert SufitDepartment of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Ill.
Tamar S PolonskyDepartment of Medicine, University of Chicago, Chicago, Ill.
Melina R KibbeDivision of Vascular and Endovascular Surgery, Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Philip GreenlandDepartment of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Ill.
Christiaan LeeuwenburghDepartment of Aging and Geriatric Research, University of Florida, Gainesville, Fla.
Jack M GuralnikDepartment of Epidemiology, University of Maryland, College Park, Md.

Funding

WOMEN'S INTERAGENCY HIV STUDY (WIHS) INTENSIVE PHARMACOKINETICS STUDYM01RR000048 · NCRR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI DUNAIF, ANDREA · 1985 to 2007
$21.1M
TELmisartan plus EXercise to improve functioning in PAD: The TELEX TrialR01HL126117 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MCDERMOTT, MARY MCGRAE · 2015 to 2019
$3.7M
Magnetic Resonance in Peripheral Arterial DiseaseR01HL083064 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MCDERMOTT, MARY MCGRAE · 2007 to 2010
$2.9M
Mechanisms of Disability in Peripheral Arterial DiseaseR01HL071223 · NHLBI · NORTHWESTERN UNIVERSITY · PI MCDERMOTT, MARY MCGRAE · 2002 to 2005
$2.7M
BLOOD FACTORS AND PERIPHERAL ARTERIAL DISEASE OUTCOMESR01HL064739 · NHLBI · NORTHWESTERN UNIVERSITY · PI MCDERMOTT, MARY MCGRAE · 2001 to 2004
$2.1M
NCRR NIH HHS M01 RR000048NHLBI NIH HHS R01 HL064739NHLBI NIH HHS R01 HL071223NHLBI NIH HHS R01 HL083064NHLBI NIH HHS R01 HL126117
6 · The paper itself

Abstract

objectiveThe 6-minute walk test is a common outcome measure in clinical trials of people with lower extremity peripheral artery disease (PAD). However, what constitutes a meaningful change in the 6-minute walk distance has not been well defined for people with PAD. The present study related the change in the 6-minute walk distance to the degree of participant-reported improvement or decline in the 6-minute walk distance to define a meaningful change in the 6-minute walk distance for those with PAD.

methodsParticipants with PAD from three observational longitudinal studies completed the walking impairment questionnaire (WIQ) distance score and 6-minute walk at baseline and 1 year later. The WIQ distance score measures participants' perceived difficulty walking seven different distances without stopping (ranging from walking around the home to walking 5 blocks) on a 0 to 4 Likert scale, with 0 representing an inability to walk the distance and 4 representing no difficulty. The mean changes in the 6-minute walk distance corresponding to the participants' report of no change, 1-unit change, or 2-unit change, respectively, in the Likert scale score between the baseline and 1-year follow-up measures were calculated for each WIQ distance.

resultsA total of 777 participants with PAD (mean age, 71.2 ± 8.8 years; mean baseline 6-minute walk distance, 350.1 ± 118.1 meters) completed 5439 questions about their difficulty walking each WIQ distance at baseline and follow-up. Participants with PAD who reported no change in their difficulty in walking each WIQ distance between baseline and follow-up had a decline of 7.2 meters (95% confidence interval [CI], -11.6 to -2.8 meters) in the 6-minute walk test. Relative to those reporting no change in difficulty walking, the participants reporting 1- and 2-point improvements in walking ability showed 6-minute walk distance improvements of 7.8 meters (95% CI, -0.3 to 15.9 meters) and 20.1 meters (95% CI, 1.1-39.2 meters), respectively. Relative to those reporting no change in walking difficulty, those reporting 1- and 2-point declines in perceived walking difficulty showed declines of -11.2 meters (95% CI, -19.0 to -3.4 meters) and -23.8 meters (95% CI, -37.4 to -10.3 meters) in the 6-minute walk distance.

conclusionsAmong people with PAD, ∼8- and ∼20-meter improvements in the 6-minute walk distance represent small and large improvements in walking ability, respectively. People with PAD who reported no change in their ability to walk distances over 1 year simultaneously declined by a mean of 7 meters in the 6-minute walk test. These findings will be useful for interpreting the results from randomized trials of interventions to improve the walking performance of people with PAD.

Indexed as

AgedFemaleFollow-Up StudiesHumansLegMalePeripheral Arterial DiseaseSurveys and QuestionnairesWalkingWalk Test

Identifiers

PMID32335305
PMCPMC9439935

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.